Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease is also caused due to excess production of hypothalamus corticotropin releasing hormone (CRH) which stimulates the synthesis of cortisol by the adrenal glands.
Cushing’s disease treatment market revenue is growing with a stable growth rate, this is attributed to increasing number of pipeline drugs. Also increasing interest of pharmaceutical companies to develop Cushing disease drugs is a major factor contributing to the revenue growth of Cushing disease treatment market over the forecast period. Current and emerging players’ focuses on physician education and awareness regarding availability of different drugs for curing Cushing disease, thus increasing the referral speeds, time to diagnosis and volume of diagnosed Cushing disease individuals. Growing healthcare expenditure and increasing awareness regarding Cushing syndrome aids in the revenue growth of Cushing’s disease treatment market. Increasing number of new product launches also drives the market for Cushing’s disease Treatment devices. However availability of alternative therapies for curing Cushing syndrome is expected to hamper the growth of the Cushing’s disease treatment market over the forecast period.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Cushing’s Disease Treatment market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Cushing’s Disease Treatment market. Detailed analysis of key players, along with key growth strategies adopted by Cushing’s Disease Treatment industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Strongbridge Biopharma
CORCEPT THERAPEUTICS
Novartis
HRA Pharma
By Type:
Ketoconazole
Mitotane
Aminoglutethimide
Metyrapone
Mifepristone
Etomidate
Pasireotide
By End-User:
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Clinics
E-Commerce/Online Pharmacies
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Cushing’s Disease Treatment Market
-
1.3 Market Segment by Type
-
1.3.1 China Cushing’s Disease Treatment Market Size and Growth Rate of Ketoconazole from 2016 to 2027
-
1.3.2 China Cushing’s Disease Treatment Market Size and Growth Rate of Mitotane from 2016 to 2027
-
1.3.3 China Cushing’s Disease Treatment Market Size and Growth Rate of Aminoglutethimide from 2016 to 2027
-
1.3.4 China Cushing’s Disease Treatment Market Size and Growth Rate of Metyrapone from 2016 to 2027
-
1.3.5 China Cushing’s Disease Treatment Market Size and Growth Rate of Mifepristone from 2016 to 2027
-
1.3.6 China Cushing’s Disease Treatment Market Size and Growth Rate of Etomidate from 2016 to 2027
-
1.3.7 China Cushing’s Disease Treatment Market Size and Growth Rate of Pasireotide from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Cushing’s Disease Treatment Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
1.4.2 China Cushing’s Disease Treatment Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
1.4.3 China Cushing’s Disease Treatment Market Size and Growth Rate of Drug Stores from 2016 to 2027
-
1.4.4 China Cushing’s Disease Treatment Market Size and Growth Rate of Clinics from 2016 to 2027
-
1.4.5 China Cushing’s Disease Treatment Market Size and Growth Rate of E-Commerce/Online Pharmacies from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Cushing’s Disease Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Cushing’s Disease Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Cushing’s Disease Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Cushing’s Disease Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Cushing’s Disease Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Cushing’s Disease Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Cushing’s Disease Treatment Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Cushing’s Disease Treatment Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Cushing’s Disease Treatment by Major Types
-
3.4.1 Market Size and Growth Rate of Ketoconazole
-
3.4.2 Market Size and Growth Rate of Mitotane
-
3.4.3 Market Size and Growth Rate of Aminoglutethimide
-
3.4.4 Market Size and Growth Rate of Metyrapone
-
3.4.5 Market Size and Growth Rate of Mifepristone
-
3.4.6 Market Size and Growth Rate of Etomidate
-
3.4.7 Market Size and Growth Rate of Pasireotide
4 Segmentation of Cushing’s Disease Treatment Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Cushing’s Disease Treatment by Major End-Users
-
4.4.1 Market Size and Growth Rate of Cushing’s Disease Treatment in Hospital Pharmacies
-
4.4.2 Market Size and Growth Rate of Cushing’s Disease Treatment in Retail Pharmacies
-
4.4.3 Market Size and Growth Rate of Cushing’s Disease Treatment in Drug Stores
-
4.4.4 Market Size and Growth Rate of Cushing’s Disease Treatment in Clinics
-
4.4.5 Market Size and Growth Rate of Cushing’s Disease Treatment in E-Commerce/Online Pharmacies
5 Market Analysis by Regions
-
5.1 China Cushing’s Disease Treatment Production Analysis by Regions
-
5.2 China Cushing’s Disease Treatment Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Cushing’s Disease Treatment Landscape Analysis
-
6.1 North China Cushing’s Disease Treatment Landscape Analysis by Major Types
-
6.2 North China Cushing’s Disease Treatment Landscape Analysis by Major End-Users
7 Central China Cushing’s Disease Treatment Landscape Analysis
-
7.1 Central China Cushing’s Disease Treatment Landscape Analysis by Major Types
-
7.2 Central China Cushing’s Disease Treatment Landscape Analysis by Major End-Users
8 South China Cushing’s Disease Treatment Landscape Analysis
-
8.1 South China Cushing’s Disease Treatment Landscape Analysis by Major Types
-
8.2 South China Cushing’s Disease Treatment Landscape Analysis by Major End-Users
9 East China Cushing’s Disease Treatment Landscape Analysis
-
9.1 East China Cushing’s Disease Treatment Landscape Analysis by Major Types
-
9.2 East China Cushing’s Disease Treatment Landscape Analysis by Major End-Users
10 Northeast China Cushing’s Disease Treatment Landscape Analysis
-
10.1 Northeast China Cushing’s Disease Treatment Landscape Analysis by Major Types
-
10.2 Northeast China Cushing’s Disease Treatment Landscape Analysis by Major End-Users
11 Southwest China Cushing’s Disease Treatment Landscape Analysis
-
11.1 Southwest China Cushing’s Disease Treatment Landscape Analysis by Major Types
-
11.2 Southwest China Cushing’s Disease Treatment Landscape Analysis by Major End-Users
12 Northwest China Cushing’s Disease Treatment Landscape Analysis
-
12.1 Northwest China Cushing’s Disease Treatment Landscape Analysis by Major Types
-
12.2 Northwest China Cushing’s Disease Treatment Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Strongbridge Biopharma
-
13.1.1 Strongbridge Biopharma Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 CORCEPT THERAPEUTICS
-
13.2.1 CORCEPT THERAPEUTICS Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Novartis
-
13.3.1 Novartis Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 HRA Pharma
-
13.4.1 HRA Pharma Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Cushing’s Disease Treatment Market Size and Growth Rate of Ketoconazole from 2016 to 2027
-
Figure China Cushing’s Disease Treatment Market Size and Growth Rate of Mitotane from 2016 to 2027
-
Figure China Cushing’s Disease Treatment Market Size and Growth Rate of Aminoglutethimide from 2016 to 2027
-
Figure China Cushing’s Disease Treatment Market Size and Growth Rate of Metyrapone from 2016 to 2027
-
Figure China Cushing’s Disease Treatment Market Size and Growth Rate of Mifepristone from 2016 to 2027
-
Figure China Cushing’s Disease Treatment Market Size and Growth Rate of Etomidate from 2016 to 2027
-
Figure China Cushing’s Disease Treatment Market Size and Growth Rate of Pasireotide from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Cushing’s Disease Treatment Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
Figure China Cushing’s Disease Treatment Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
Figure China Cushing’s Disease Treatment Market Size and Growth Rate of Drug Stores from 2016 to 2027
-
Figure China Cushing’s Disease Treatment Market Size and Growth Rate of Clinics from 2016 to 2027
-
Figure China Cushing’s Disease Treatment Market Size and Growth Rate of E-Commerce/Online Pharmacies from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Cushing’s Disease Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Cushing’s Disease Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Cushing’s Disease Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Cushing’s Disease Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Cushing’s Disease Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Cushing’s Disease Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Cushing’s Disease Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Cushing’s Disease Treatment Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Cushing’s Disease Treatment
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Cushing’s Disease Treatment by Different Types from 2016 to 2027
-
Table Consumption Share of Cushing’s Disease Treatment by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Ketoconazole
-
Figure Market Size and Growth Rate of Mitotane
-
Figure Market Size and Growth Rate of Aminoglutethimide
-
Figure Market Size and Growth Rate of Metyrapone
-
Figure Market Size and Growth Rate of Mifepristone
-
Figure Market Size and Growth Rate of Etomidate
-
Figure Market Size and Growth Rate of Pasireotide
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Cushing’s Disease Treatment by Different End-Users from 2016 to 2027
-
Table Consumption Share of Cushing’s Disease Treatment by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital Pharmacies
-
Figure Market Size and Growth Rate of Retail Pharmacies
-
Figure Market Size and Growth Rate of Drug Stores
-
Figure Market Size and Growth Rate of Clinics
-
Figure Market Size and Growth Rate of E-Commerce/Online Pharmacies
-
Table China Cushing’s Disease Treatment Production by Regions
-
Table China Cushing’s Disease Treatment Production Share by Regions
-
Figure China Cushing’s Disease Treatment Production Share by Regions in 2016
-
Figure China Cushing’s Disease Treatment Production Share by Regions in 2021
-
Figure China Cushing’s Disease Treatment Production Share by Regions in 2027
-
Table China Cushing’s Disease Treatment Consumption by Regions
-
Table China Cushing’s Disease Treatment Consumption Share by Regions
-
Figure China Cushing’s Disease Treatment Consumption Share by Regions in 2016
-
Figure China Cushing’s Disease Treatment Consumption Share by Regions in 2021
-
Figure China Cushing’s Disease Treatment Consumption Share by Regions in 2027
-
Table North China Cushing’s Disease Treatment Consumption by Types from 2016 to 2027
-
Table North China Cushing’s Disease Treatment Consumption Share by Types from 2016 to 2027
-
Figure North China Cushing’s Disease Treatment Consumption Share by Types in 2016
-
Figure North China Cushing’s Disease Treatment Consumption Share by Types in 2021
-
Figure North China Cushing’s Disease Treatment Consumption Share by Types in 2027
-
Table North China Cushing’s Disease Treatment Consumption by End-Users from 2016 to 2027
-
Table North China Cushing’s Disease Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure North China Cushing’s Disease Treatment Consumption Share by End-Users in 2016
-
Figure North China Cushing’s Disease Treatment Consumption Share by End-Users in 2021
-
Figure North China Cushing’s Disease Treatment Consumption Share by End-Users in 2027
-
Table Central China Cushing’s Disease Treatment Consumption by Types from 2016 to 2027
-
Table Central China Cushing’s Disease Treatment Consumption Share by Types from 2016 to 2027
-
Figure Central China Cushing’s Disease Treatment Consumption Share by Types in 2016
-
Figure Central China Cushing’s Disease Treatment Consumption Share by Types in 2021
-
Figure Central China Cushing’s Disease Treatment Consumption Share by Types in 2027
-
Table Central China Cushing’s Disease Treatment Consumption by End-Users from 2016 to 2027
-
Table Central China Cushing’s Disease Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Cushing’s Disease Treatment Consumption Share by End-Users in 2016
-
Figure Central China Cushing’s Disease Treatment Consumption Share by End-Users in 2021
-
Figure Central China Cushing’s Disease Treatment Consumption Share by End-Users in 2027
-
Table South China Cushing’s Disease Treatment Consumption by Types from 2016 to 2027
-
Table South China Cushing’s Disease Treatment Consumption Share by Types from 2016 to 2027
-
Figure South China Cushing’s Disease Treatment Consumption Share by Types in 2016
-
Figure South China Cushing’s Disease Treatment Consumption Share by Types in 2021
-
Figure South China Cushing’s Disease Treatment Consumption Share by Types in 2027
-
Table South China Cushing’s Disease Treatment Consumption by End-Users from 2016 to 2027
-
Table South China Cushing’s Disease Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure South China Cushing’s Disease Treatment Consumption Share by End-Users in 2016
-
Figure South China Cushing’s Disease Treatment Consumption Share by End-Users in 2021
-
Figure South China Cushing’s Disease Treatment Consumption Share by End-Users in 2027
-
Table East China Cushing’s Disease Treatment Consumption by Types from 2016 to 2027
-
Table East China Cushing’s Disease Treatment Consumption Share by Types from 2016 to 2027
-
Figure East China Cushing’s Disease Treatment Consumption Share by Types in 2016
-
Figure East China Cushing’s Disease Treatment Consumption Share by Types in 2021
-
Figure East China Cushing’s Disease Treatment Consumption Share by Types in 2027
-
Table East China Cushing’s Disease Treatment Consumption by End-Users from 2016 to 2027
-
Table East China Cushing’s Disease Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure East China Cushing’s Disease Treatment Consumption Share by End-Users in 2016
-
Figure East China Cushing’s Disease Treatment Consumption Share by End-Users in 2021
-
Figure East China Cushing’s Disease Treatment Consumption Share by End-Users in 2027
-
Table Northeast China Cushing’s Disease Treatment Consumption by Types from 2016 to 2027
-
Table Northeast China Cushing’s Disease Treatment Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Cushing’s Disease Treatment Consumption Share by Types in 2016
-
Figure Northeast China Cushing’s Disease Treatment Consumption Share by Types in 2021
-
Figure Northeast China Cushing’s Disease Treatment Consumption Share by Types in 2027
-
Table Northeast China Cushing’s Disease Treatment Consumption by End-Users from 2016 to 2027
-
Table Northeast China Cushing’s Disease Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Cushing’s Disease Treatment Consumption Share by End-Users in 2016
-
Figure Northeast China Cushing’s Disease Treatment Consumption Share by End-Users in 2021
-
Figure Northeast China Cushing’s Disease Treatment Consumption Share by End-Users in 2027
-
Table Southwest China Cushing’s Disease Treatment Consumption by Types from 2016 to 2027
-
Table Southwest China Cushing’s Disease Treatment Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Cushing’s Disease Treatment Consumption Share by Types in 2016
-
Figure Southwest China Cushing’s Disease Treatment Consumption Share by Types in 2021
-
Figure Southwest China Cushing’s Disease Treatment Consumption Share by Types in 2027
-
Table Southwest China Cushing’s Disease Treatment Consumption by End-Users from 2016 to 2027
-
Table Southwest China Cushing’s Disease Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Cushing’s Disease Treatment Consumption Share by End-Users in 2016
-
Figure Southwest China Cushing’s Disease Treatment Consumption Share by End-Users in 2021
-
Figure Southwest China Cushing’s Disease Treatment Consumption Share by End-Users in 2027
-
Table Northwest China Cushing’s Disease Treatment Consumption by Types from 2016 to 2027
-
Table Northwest China Cushing’s Disease Treatment Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Cushing’s Disease Treatment Consumption Share by Types in 2016
-
Figure Northwest China Cushing’s Disease Treatment Consumption Share by Types in 2021
-
Figure Northwest China Cushing’s Disease Treatment Consumption Share by Types in 2027
-
Table Northwest China Cushing’s Disease Treatment Consumption by End-Users from 2016 to 2027
-
Table Northwest China Cushing’s Disease Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Cushing’s Disease Treatment Consumption Share by End-Users in 2016
-
Figure Northwest China Cushing’s Disease Treatment Consumption Share by End-Users in 2021
-
Figure Northwest China Cushing’s Disease Treatment Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Strongbridge Biopharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Strongbridge Biopharma
-
Figure Sales and Growth Rate Analysis of Strongbridge Biopharma
-
Figure Revenue and Market Share Analysis of Strongbridge Biopharma
-
Table Product and Service Introduction of Strongbridge Biopharma
-
Table Company Profile and Development Status of CORCEPT THERAPEUTICS
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CORCEPT THERAPEUTICS
-
Figure Sales and Growth Rate Analysis of CORCEPT THERAPEUTICS
-
Figure Revenue and Market Share Analysis of CORCEPT THERAPEUTICS
-
Table Product and Service Introduction of CORCEPT THERAPEUTICS
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of HRA Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of HRA Pharma
-
Figure Sales and Growth Rate Analysis of HRA Pharma
-
Figure Revenue and Market Share Analysis of HRA Pharma
-
Table Product and Service Introduction of HRA Pharma
-
